抑制剂-话题@MedSci

#抑制剂#

1990篇内容 | 3110人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1852581, encodeId=fee71852581b4, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=BMJ：SGLT-2抑制剂或GLP-1受体激动剂治疗糖尿病的临床优势, objectType=article, longId=205766, objectId=c84a205e66fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84a205e66fd, replyNumber=0, likeNumber=134, createdTime=2021-05-21, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84a205e66fd, moduleTitle=BMJ：SGLT-2抑制剂或GLP-1受体激动剂治疗糖尿病的临床优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c84a205e66fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852496, encodeId=d07f18524967b, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Hypertension：蛋白尿与肾素-血管紧张素系统抑制剂处方之间的关系, objectType=article, longId=201363, objectId=06d72013630b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06d72013630b, replyNumber=0, likeNumber=89, createdTime=2020-12-07, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06d72013630b, moduleTitle=Hypertension：蛋白尿与肾素-血管紧张素系统抑制剂处方之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06d72013630b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852638, encodeId=b8371852638a9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病, objectType=article, longId=210383, objectId=687e210383ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=687e210383ae, replyNumber=0, likeNumber=95, createdTime=2022-03-31, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=687e210383ae, moduleTitle=J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=687e210383ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852514, encodeId=d7501852514f8, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=J Clin Oncol：新型LSD1抑制剂Iadademstat单一治疗复发/难治性AML初露成效, objectType=article, longId=202153, objectId=31d82021531a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31d82021531a, replyNumber=0, likeNumber=112, createdTime=2021-07-06, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31d82021531a, moduleTitle=J Clin Oncol：新型LSD1抑制剂Iadademstat单一治疗复发/难治性AML初露成效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31d82021531a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852580, encodeId=feab18525806d, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=J Immunother Cancer：采用免疫检查点抑制剂治疗的黑色素瘤患者静脉血栓栓塞的发生率, objectType=article, longId=205720, objectId=6c70205e20be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c70205e20be, replyNumber=0, likeNumber=88, createdTime=2021-12-14, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c70205e20be, moduleTitle=J Immunother Cancer：采用免疫检查点抑制剂治疗的黑色素瘤患者静脉血栓栓塞的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c70205e20be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852621, encodeId=329e185262186, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Neurology：胆碱酯酶抑制剂对认知衰退和死亡率的长期影响, objectType=article, longId=208958, objectId=272f208958d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=272f208958d3, replyNumber=0, likeNumber=97, createdTime=2021-04-17, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=272f208958d3, moduleTitle=Neurology：胆碱酯酶抑制剂对认知衰退和死亡率的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=272f208958d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852616, encodeId=0e821852616c3, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！, objectType=article, longId=208138, objectId=ca0a2081382a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0a2081382a, replyNumber=0, likeNumber=87, createdTime=2021-08-07, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0a2081382a, moduleTitle=新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca0a2081382a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852529, encodeId=6034185252983, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=关节炎药物JAK抑制剂Baricitinib治疗斑秃：患者获得显著改善, objectType=article, longId=202774, objectId=0f2d202e740f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f2d202e740f, replyNumber=0, likeNumber=0, createdTime=2021-05-28, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f2d202e740f, moduleTitle=关节炎药物JAK抑制剂Baricitinib治疗斑秃：患者获得显著改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f2d202e740f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852545, encodeId=82941852545fe, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定, objectType=article, longId=203551, objectId=920d203551ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920d203551ad, replyNumber=0, likeNumber=88, createdTime=2021-01-21, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920d203551ad, moduleTitle=BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920d203551ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852585, encodeId=d58a185258583, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=BMJ子刊：基于真实世界研究，长期使用DPP-4抑制剂对2型糖尿病患者的安全性和有效性, objectType=article, longId=205874, objectId=7eb72058e492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eb72058e492, replyNumber=0, likeNumber=86, createdTime=2021-05-05, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eb72058e492, moduleTitle=BMJ子刊：基于真实世界研究，长期使用DPP-4抑制剂对2型糖尿病患者的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7eb72058e492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852612, encodeId=f2281852612c5, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Cancer Discov：新型EGFR抑制剂Mobocertinib用于携带EGFRex20ins突变的NSCLC患者的疗效和安全性, objectType=article, longId=207727, objectId=85a920e727bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85a920e727bb, replyNumber=0, likeNumber=82, createdTime=2022-01-02, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85a920e727bb, moduleTitle=Cancer Discov：新型EGFR抑制剂Mobocertinib用于携带EGFRex20ins突变的NSCLC患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85a920e727bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852566, encodeId=7254185256601, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Circulation：免疫检查点抑制剂治疗可加快动脉粥样硬化斑块进展, objectType=article, longId=204753, objectId=0b83204e5304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b83204e5304, replyNumber=0, likeNumber=0, createdTime=2021-07-31, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b83204e5304, moduleTitle=Circulation：免疫检查点抑制剂治疗可加快动脉粥样硬化斑块进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b83204e5304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852575, encodeId=dd1618525e547, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=KRAS抑制剂Adagrasib与Sotorasib治疗肺癌对比, objectType=article, longId=205368, objectId=7c3220536802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c3220536802, replyNumber=0, likeNumber=105, createdTime=2021-09-10, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c3220536802, moduleTitle=KRAS抑制剂Adagrasib与Sotorasib治疗肺癌对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c3220536802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852606, encodeId=d2eb1852606e7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=ASCO GU 2021: DPP4抑制剂对糖尿病合并前列腺癌患者PFS的影响, objectType=article, longId=207263, objectId=8b0220e263c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b0220e263c4, replyNumber=0, likeNumber=73, createdTime=2021-04-03, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b0220e263c4, moduleTitle=ASCO GU 2021: DPP4抑制剂对糖尿病合并前列腺癌患者PFS的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b0220e263c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852552, encodeId=e76a1852552cb, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Br J Oral Maxillofac Surg：肿瘤坏死因子-α（TNF-α）抑制剂相关的下颌骨坏死和骨髓炎：一项系统性回顾 , objectType=article, longId=204096, objectId=ce2a204096a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce2a204096a1, replyNumber=0, likeNumber=89, createdTime=2020-12-06, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce2a204096a1, moduleTitle=Br J Oral Maxillofac Surg：肿瘤坏死因子-α（TNF-α）抑制剂相关的下颌骨坏死和骨髓炎：一项系统性回顾 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce2a204096a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852633, encodeId=13001852633aa, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JNNP：TNF抑制剂治疗抗MOG相关脑炎伴癫痫（FLAMES）的单侧皮质FLAIR高信号病变, objectType=article, longId=209839, objectId=4a4820983914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a4820983914, replyNumber=0, likeNumber=95, createdTime=2021-04-20, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a4820983914, moduleTitle=JNNP：TNF抑制剂治疗抗MOG相关脑炎伴癫痫（FLAMES）的单侧皮质FLAIR高信号病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a4820983914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852553, encodeId=44e418525530c, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=FDA批准RET抑制剂pralsetinib新适应症！治疗甲状腺髓样癌, objectType=article, longId=204111, objectId=394820411175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394820411175, replyNumber=0, likeNumber=97, createdTime=2021-07-09, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394820411175, moduleTitle=FDA批准RET抑制剂pralsetinib新适应症！治疗甲状腺髓样癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=394820411175)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852668, encodeId=7fa618526685c, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=ASCO 2021: 摘要概览与展望 7| PD-1抑制剂Keytruda冲击胃癌一线疗法新进展！, objectType=article, longId=211864, objectId=907c211864e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907c211864e9, replyNumber=0, likeNumber=93, createdTime=2021-10-13, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907c211864e9, moduleTitle=ASCO 2021: 摘要概览与展望 7| PD-1抑制剂Keytruda冲击胃癌一线疗法新进展！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907c211864e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852473, encodeId=f10518524e368, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Lancet：SGLT2抑制剂对射血分数降低的心衰患者各类预后的影响, objectType=article, longId=200115, objectId=f8af20011537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8af20011537, replyNumber=0, likeNumber=111, createdTime=2020-11-12, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8af20011537, moduleTitle=Lancet：SGLT2抑制剂对射血分数降低的心衰患者各类预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8af20011537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852619, encodeId=c0ba1852619dc, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Science Advance：LSD1酶抑制剂TAK-418可改善自闭症！, objectType=article, longId=208367, objectId=332820836ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=332820836ef1, replyNumber=0, likeNumber=124, createdTime=2022-01-17, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=332820836ef1, moduleTitle=Science Advance：LSD1酶抑制剂TAK-418可改善自闭症！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=332820836ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抑制剂

2020-05-29

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

BMJ：SGLT-2抑制剂或GLP-1受体激动剂治疗糖尿病的临床优势

2021-05-21

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Hypertension：蛋白尿与肾素-血管紧张素系统抑制剂处方之间的关系

2020-12-07

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病

2022-03-31

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

J Clin Oncol：新型LSD1抑制剂Iadademstat单一治疗复发/难治性AML初露成效

2021-07-06

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

J Immunother Cancer：采用免疫检查点抑制剂治疗的黑色素瘤患者静脉血栓栓塞的发生率

2021-12-14

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Neurology：胆碱酯酶抑制剂对认知衰退和死亡率的长期影响

2021-04-17

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！

2021-08-07

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

关节炎药物JAK抑制剂Baricitinib治疗斑秃：患者获得显著改善

2021-05-28

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定

2021-01-21

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

BMJ子刊：基于真实世界研究，长期使用DPP-4抑制剂对2型糖尿病患者的安全性和有效性

2021-05-05

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Cancer Discov：新型EGFR抑制剂Mobocertinib用于携带EGFRex20ins突变的NSCLC患者的疗效和安全性

2022-01-02

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Circulation：免疫检查点抑制剂治疗可加快动脉粥样硬化斑块进展

2021-07-31

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

KRAS抑制剂Adagrasib与Sotorasib治疗肺癌对比

2021-09-10

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

ASCO GU 2021: DPP4抑制剂对糖尿病合并前列腺癌患者PFS的影响

2021-04-03

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Br J Oral Maxillofac Surg：肿瘤坏死因子-α（TNF-α）抑制剂相关的下颌骨坏死和骨髓炎：一项系统性回顾

2020-12-06

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JNNP：TNF抑制剂治疗抗MOG相关脑炎伴癫痫（FLAMES）的单侧皮质FLAIR高信号病变

2021-04-20

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

FDA批准RET抑制剂pralsetinib新适应症！治疗甲状腺髓样癌

2021-07-09

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

ASCO 2021: 摘要概览与展望 7| PD-1抑制剂Keytruda冲击胃癌一线疗法新进展！

2021-10-13

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Lancet：SGLT2抑制剂对射血分数降低的心衰患者各类预后的影响

2020-11-12

docwu2019 (审核中...)

前往app查看评论内容

#抑制剂#

Science Advance：LSD1酶抑制剂TAK-418可改善自闭症！

2022-01-17

科室
- - 订阅+
  - 更多科室
工具
服务